Thrombosis Research
Volume 125 , Pages S7-S10 , April 2010

Recent Estimates of the Structure of the Factor VIIa (FVIIa)/Tissue Factor (TF) and Factor Xa (FXa) Ternary Complex

  • Chang Jun Lee

      Affiliations

    • Department of Chemistry, University of North Carolina, Chapel Hill, North Carolina 27599-3290, USA
    • ,
  • Vasu Chandrasekaran

      Affiliations

    • Novartis Institutes for Biomedical Research, Cambridge, MA, USA 02139
    • ,
  • Sangwook Wu

      Affiliations

    • Department of Chemistry, University of North Carolina, Chapel Hill, North Carolina 27599-3290, USA
    • ,
  • Robert E. Duke

      Affiliations

    • Department of Chemistry, University of North Carolina, Chapel Hill, North Carolina 27599-3290, USA
    • ,
  • Lee G. Pedersen

      Affiliations

    • Department of Chemistry, University of North Carolina, Chapel Hill, North Carolina 27599-3290, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 919 962 1578; fax: +1 919 962 2388.

References 

  1. Roberts HR, Tabares AH. Overview of the coagulation reactions. In:  High KA,  Roberts HR editor. Molecular Basis of Thrombosis and Haemostatis. New York: Marcel Dekker; 1995;p. 35–50
  2. Hoffman M, Monroe DM. A cell-based model of hemostasis. ThrombHaemost. 2001;85:958–965
  3. Roberts HR, Hoffman M, Monroe DM. A cell-based model of thrombin generation. Sem Thromb Hemost. 2006;32:32–38
  4. Banner DW, Darcy A, Chene C, Winkler FK, Guha A, Konigsberg WH, et al. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature. 1996;380:41–46
  5. Zhang E, St Charles R, Tulinsky A. Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant. J Mol Biol. 1999;285:2089–2104
  6. Bajaj SP, Schmidt AE, Agah S, Bajaj MS, Padmanabhan K. High resolution structures of p-aminobenzamidine and benzamindine-VIIa soluble tissue factor– Unpredicted conformation of the 192-193 peptide bond and mapping of Ca2+, Mg2+, Na+ and Zn2+ sites in factor VIIa. J Biol Chem. 2006;281:24873–24888
  7. Norledge BV, Petrovan RJ, Ruf W, Olson AJ. The tissue factor/factor VIIa/factor Xa complex: A model built by docking and site-directed mutagenesis. Proteins: Struc Func and Gen. 2003;53:640–648
  8. Venkateswarlu D, Duke RE, Perera L, Darden T, Pedersen LG. An all-atom solution-equilibrated model for human extrinsic blood coagulation complex (sTF-VIIa-Xa): a protein-protein molecular dynamics refinement study. J Thromb Haem. 2003;1:2577–2588
  9. Manithody C, Yang LK, Rezaie AR. Identification of a basis region of tissue factor that interacts with the first epidermal growth factor-like domain of factor X. Biochemistry. 2007;46:3193–3199
  10. Lee CJ, Lin P, Chandrasekaran V, Duke RE, Everse SJ, Perera L, et al. Proposed structural models of human factor Va and prothrombinase. J Thromb Haem. 2007;6:83–89
  11. Darden T, York D, Pedersen L. Particle Mesh Ewald – An N logN method for Ewald sums in large systems. J Chem Phys. 1993;98:10089–10092
  12. Case DA, Darden TA, Cheatham TE, Simmerling CL, Wang J, Duke RE, et al. In: AMBER. 9:San Francisco: University of California; 2006;
  13. Jorgensen WL, Chadrasekhar J, Madura JD, Impey RW, Klein ML. Comparison of simple potential functions for simulating liquid water. J Chem Phys. 1983;79:926–935
  14. Darden T, Perera L, Li L, Pedersen L. New tricks for modelers from the crystallographic toolkit: the particle mesh Ewald algorithm and its use in nucleic acid simulations. Structure. 1999;7:R55–R60
  15. Galeazzi R. Molecular Dynamics as a tool in rational drug design: current status and some major applications. Curr Computer-aided Drug Des. 2009;5:225–240
  16. Jenwitheesuk E, Samudrala R. Improved prediction of HIV-1 protease-inhibitor binding energies by molecular dynamics simulation. BMC Struct Biol. 2003;3:2
  17. Abseher R, Horstink L, Hilbers CW, Nilges M. Essential spaces defined by NMR structure ensembles and molecular dynamics simulation show significant overlap. Proteins: Struc Func and Gen. 1998;31:370–382
  18. Li LP, Darden TA, Freedman SJ, Furie BC, Furie B, Baleja JD, et al. Refinement of the NMR solution structure of the gamma-carboxyglutamic acid domain of coagulation factor IX using molecular dynamics simulation with initial Ca2+ positions determined by a genetic algorithm. Biochemistry. 1997;36:2132–2138
  19. Tina KG, Bhadra R, Srinivasan N. Nucleic Acids Res. 2007;35:Web Server issue W473–W476
  20. Roy S, Hass PE, Bourell JH, Henzel WJ, Vehar GA. Lysine residues 165 and 166 are essential for the cofactor function of tissue factor. J Biol Chem. 1991;266:22063–22066
  21. Huang Q, Neuenschwander PF, Rezaie AR, Morrissey JH. Substrate recognition by tissue factor-factor VIIa: Evidence for interaction of residues Lys165 and Lys166 of tissue factor with the 4-carboxyglutamate-rich domain of factor X. J Biol Chem. 1996;271:21752–21757
  22. Rao LVM, Ruf W. Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor·VIIa with Xa·Tissue factor pathway inhibitor. Biochemistry. 1995;34:10867–10871
  23. Ruf W, Miles DJ, Rehemtulla A, Edgington TS. Tissue factor residues 157−167 are required for efficient proteolytic activation of factor X and factor VII. J Biol Chem. 1992;267:22206–22210
  24. Kirchhofer D, Lipari MT, Moran P, Eigenbrot C, Kelley RF. The tissue factor region that interacts with substrates factor IX and Factor X. Biochemistry. 2000;39:7380–7387
  25. Kirchhofer D, Eigenbrot C, Lipari MT, Moran P, Peek M, Kelley RF. The tissue factor region that interacts with factor Xa in the Activation of factor VII. Biochemistry. 2001;40:675–682
  26. Wiréhn J, Carlsson K, Herland A, Persson E, Carlsson U, Svensson M, et al. Activity, folding, misfolding, and aggregation in vitro of the naturally occurring human tissue factor mutant R200W. Biochemistry. 2005;44:6755–6763
  27. Carlsson K, Freskgård P, Persson E, Sralsson U, Svensson M. Probing the interface between factor Xa and tissue factor in the quaternary complex tissue factor-factor VIIa-factor Xa-tissue factor pathway inhibitor. Eur J Biochem. 2003;270:2576–2582
  28. Ruf W, Shobe J, Rao SM, Dickinson CD, Olson A, Edgington TS. Importance of factor VIIa Gla-domain residue Arg-36 for recognition of the macromolecular substrate factor X Gla-domain. Biochemistry. 1999;38:1957–1966
  29. Persson E, Olsen OH. Assignment of molecular properties of a superactive coagulation factor VIIa variant to individual amino acid changes. Eur J Biochem. 2002;269:5950–5955
  30. Bjelke JR, Persson E, Rasmussen HB, Kragelund BB, Olsen OH. A loop of coagulation factor VIIa influencing macromolecular substrate specificity. FEBS Lett. 2007;581:71–76
  31. Toso R, Pinotti M, High KA, Pollak ES, Bernardi F. A frequent human coagulation Factor VII mutation (A294V, c152) in loop 140s affects the interaction with activators, tissue factor and substrates. Biochem J. 2002;363:411–416
  32. Ruf Wolfram. Factor VIIa residue Arg290 is required for efficient activation of the macromolecular substrate factor X. Biochemistry. 1994;33:11631

PII: S0049-3848(10)00075-7

doi: 10.1016/j.thromres.2010.01.022

Thrombosis Research
Volume 125 , Pages S7-S10 , April 2010

Article Tools

* Image Usage & Resolution